Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

Amazon develops messaging app 'Anytime' to rival Facebook and Whatsapp

Amazon is expanding into yet another market with its plans to develop a social media messaging app
Amazon
Amazon seems to be taking over the world of tech

Amazon.com Inc. (NASDAQ:AMZN) is said to be working a new messaging app to compete with Facebook and Whatsapp.

The messaging service, called Anytime, will allow users to send messages, videos and photos, according to a report by AFTV news.

The app will also let people get involved in group interaction, including playing games and listening to music together.

Messages will be encrypted to provide private conversations – a feature in Facebook-owned Whatsapp that has been heavily criticised by Prime Minister Theresa May in the government’s efforts to crack down on crime and tackle terrorism.

Amazon has begun surveying customers about the features they would like to be included in the Anytime app but it is unclear when it will be released.

Users will be able to search for people by typing their name, doing away with the need for a phone number in the same way Facebook messenger works.

The app will be compatible with desktop and mobile phones, including Android and the iPhone’s iOS.

The news comes in the wake of reports that Amazon was considering a takeover of Slack, a corporate messaging and software start-up.

Amazon has also been expanding its online grocery division, having recently announced the acquisition of Whole Foods Market Inc (NASDAQ:WFM).

Elsewhere, Amazon has been preparing to take the lead in voice commerce with its Alexa-enabled devices, including the Echo smart speakers and Fire tablets.

Last week the company held its Amazon Prime Day, putting its Echo products on sale. The Echo Dot was this year’s biggest seller while Fire tablets also saw record sales.

View full AMZN profile View Profile

Amazon.com Timeline

Related Articles

H&T Pawnbrokers store
November 15 2017
“We have delivered a strong trading performance during the second half in the key segments of Pawnbroking, Retail and Personal Loans”
Medical tests
July 11 2017
In an operational update, the medical services and software company said a multi-centre investigator led study comprising data from 607 patients at two academic university hospitals has now been completed

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use